Zhaoke Ophthalmology Enrols the First Patient for the Additional Phase III Clinical Trial of the Self-Developed Innovative Drug CsA Ophthalmic Gel

Zhaoke Ophthalmology Recruits First Patient for Innovative Presbyopia Drug BRIMOCHOLTM PF’s Phase II Trial and Expands Presence in the Middle East

Zhaoke Ophthalmology Announces 2024 Annual Results

Zhaoke Ophthalmology Partners with AFT Pharmaceuticals Limited To Commercialize BRIMOCHOLTM PF In Australia and New Zealand

Zhaoke Ophthalmology Obtains Regulatory Acceptance of its Abbreviated New Drug Application for NVK002 for Myopia Progression Control in Children